The combination human 13 gene mutation Detection kit (reversible terminal termination sequencing) complements the clinical trial

ABSTRACT: Interventions: Gold Standard:Comparison methods :(1) comparison of similar kits;(2) Sequencing method;Index test:Human 13 gene mutation Combination Detection Kit (reversible terminal termination sequencing method) Primary outcome(s): Lung and gastrointestinal tumor genes Study Design: Sequential

DISEASE(S): Non-small Cell Lung Cancer (nsclc), Colorectal Cancer (crc) , Gastrointestinal Stromal Tumor (gist)

PROVIDER: 2696826 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR